StocksDeepDive
Snapshot · TOPIX 500 · generated 2026-11-11 21:48 UTC

4536.T — Santen Pharmaceutical Co., Ltd.

EXPENSIVE (MOS -17.8%) · Quality 70/100

Value Score 30 days ago: 20.7 → today 16

Price
1994.5
Intrinsic value
1692.72
Margin of safety
-17.8%
Implied growth (reverse DCF)
+9.4%
model assumes +7.5%
Value Score
16
Quality
70
Psychology
-36.3
Discovery
24.4
price/volume attention only
Moat score
63.5
erosion: none

Value Score: bottom 36% of TOPIX 500 · Quality: top 20%

Dividend: 40/share (TTM) · yield 2.0% · payout 33%

Open the interactive Deep Dive for 4536.T →

Use this data programmatically

This page's numbers are also available as JSON at /api/v1/deep-dive/4536.T - see the API docs for the full read-only surface, including an MCP server for AI assistants.

Common questions

Is 4536.T undervalued?

As of 2026-11-11, 4536.T trades at 1994.5 against a computed intrinsic value of 1692.72 (-17.8% margin of safety) - StocksDeepDive's valuation label for this is EXPENSIVE. This is a described calculation from public data, not a recommendation.

What is Santen Pharmaceutical Co., Ltd.'s Value Score?

Santen Pharmaceutical Co., Ltd.'s Value Score is 16 as of 2026-11-11 - it combines value, quality, crowd psychology and market attention into one number.

Does 4536.T pay a dividend?

Yes - 4536.T's trailing twelve-month dividend is 40/share, a yield of 2.0% at the current price (as of 2026-11-11).